As digital health entrepreneurs and others with emerging technologies seek to gain adoption of their products by the healthcare, payers have been perceived as the stumbling block. But a major turning point this year was the move by the Centers for Medicare and Medicaid to finalize a rule to help commercial insurers to cover telehealth for Medicare Advantage patients.
Many payers are setting up funds, in effect, becoming strategic investors in digital health and medtech. But it remains to be seen whether this will speed up adoption of these technologies.
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
A new eBook explores the different ways public and private insurers are moving the needle forward to integrate and cover innovative technologies, such as the U.S. Food and Drug Administration’s pilot payer program launched last year and how insurers like Cigna are taking on the challenge of how to reimburse for the high cost of gene therapies.
To download the report, click on this link.
Picture: NanoStockk, Getty Images
